177 related articles for article (PubMed ID: 20183605)
41. A comparison of the enantioselectivities of human deoxycytidine kinase and human cytidine deaminase.
Shafiee M; Griffon JF; Gosselin G; Cambi A; Vincenzetti S; Vita A; Eriksson S; Imbach JL; Maury G
Biochem Pharmacol; 1998 Nov; 56(9):1237-42. PubMed ID: 9802336
[TBL] [Abstract][Full Text] [Related]
42. Mixed inhibition of adenosine deaminase activity by 1,3-dinitrobenzene: a model for understanding cell-selective neurotoxicity in chemically-induced energy deprivation syndromes in brain.
Wang Y; Liu X; Schneider B; Zverina EA; Russ K; Wijeyesakere SJ; Fierke CA; Richardson RJ; Philbert MA
Toxicol Sci; 2012 Feb; 125(2):509-21. PubMed ID: 22106038
[TBL] [Abstract][Full Text] [Related]
43. Of the Nine Cytidine Deaminase-Like Genes in Arabidopsis, Eight Are Pseudogenes and Only One Is Required to Maintain Pyrimidine Homeostasis in Vivo.
Chen M; Herde M; Witte CP
Plant Physiol; 2016 Jun; 171(2):799-809. PubMed ID: 27208239
[TBL] [Abstract][Full Text] [Related]
44. Kinetic and conformational studies of adenosine deaminase upon interaction with oxazepam and lorazepam.
Moosavi-Movahedi AA; Sepassi Tehrani H; Amanlou M; Soltani Rad MN; Hakimelahi GH; Tsai FY; Ataie G; Saboury AA; Ahmad F; Khalafi-Nezhad A; Poursasan N; Sharifizadeh A
Protein Pept Lett; 2010 Feb; 17(2):197-205. PubMed ID: 20214645
[TBL] [Abstract][Full Text] [Related]
45. A prokaryotic-type cytidine deaminase from Arabidopsis thaliana gene expression and functional characterization.
Faivre-Nitschke SE; Grienenberger JM; Gualberto JM
Eur J Biochem; 1999 Aug; 263(3):896-903. PubMed ID: 10469156
[TBL] [Abstract][Full Text] [Related]
46. Ab initio ONIOM-molecular dynamics (MD) study on the deamination reaction by cytidine deaminase.
Matsubara T; Dupuis M; Aida M
J Phys Chem B; 2007 Aug; 111(33):9965-74. PubMed ID: 17661509
[TBL] [Abstract][Full Text] [Related]
47. Cytidine deaminase enables Toll-like receptor 8 activation by cytidine or its analogs.
Furusho K; Shibata T; Sato R; Fukui R; Motoi Y; Zhang Y; Saitoh SI; Ichinohe T; Moriyama M; Nakamura S; Miyake K
Int Immunol; 2019 Mar; 31(3):167-173. PubMed ID: 30535046
[TBL] [Abstract][Full Text] [Related]
48. Carbocyclic analogues of the potent cytidine deaminase inhibitor 1-(beta-D-ribofuranosyl)-1,2-dihydropyrimidin-2-one (zebularine).
Jeong LS; Buenger G; McCormack JJ; Cooney DA; Hao Z; Marquez VE
J Med Chem; 1998 Jul; 41(14):2572-8. PubMed ID: 9651161
[TBL] [Abstract][Full Text] [Related]
49. Substrate analogues for an RNA-editing adenosine deaminase: mechanistic investigation and inhibitor design.
Véliz EA; Easterwood LM; Beal PA
J Am Chem Soc; 2003 Sep; 125(36):10867-76. PubMed ID: 12952466
[TBL] [Abstract][Full Text] [Related]
50. Diverse functions for DNA and RNA editing in the immune system.
Hamilton CE; Papavasiliou FN; Rosenberg BR
RNA Biol; 2010; 7(2):220-8. PubMed ID: 20220309
[TBL] [Abstract][Full Text] [Related]
51. Advantages and disadvantages of cytidine deamination.
Cascalho M
J Immunol; 2004 Jun; 172(11):6513-8. PubMed ID: 15153462
[TBL] [Abstract][Full Text] [Related]
52. Origin of tight binding of a near-perfect transition-state analogue by cytidine deaminase: implications for enzyme catalysis.
Guo H; Rao N; Xu Q; Guo H
J Am Chem Soc; 2005 Mar; 127(9):3191-7. PubMed ID: 15740159
[TBL] [Abstract][Full Text] [Related]
53. Flight of a cytidine deaminase complex with an imperfect transition state analogue inhibitor: mass spectrometric evidence for the presence of a trapped water molecule.
Schroeder GK; Zhou L; Snider MJ; Chen X; Wolfenden R
Biochemistry; 2012 Aug; 51(32):6476-86. PubMed ID: 22775299
[TBL] [Abstract][Full Text] [Related]
54. The measurement of nucleoside deaminases by high performance liquid chromatography and their use in clinical chemistry.
Sherwood RA
Biomed Chromatogr; 1991 Nov; 5(6):235-9. PubMed ID: 1760590
[TBL] [Abstract][Full Text] [Related]
55. Structural and kinetic characterization of Escherichia coli TadA, the wobble-specific tRNA deaminase.
Kim J; Malashkevich V; Roday S; Lisbin M; Schramm VL; Almo SC
Biochemistry; 2006 May; 45(20):6407-16. PubMed ID: 16700551
[TBL] [Abstract][Full Text] [Related]
56. 15N kinetic isotope effects on uncatalyzed and enzymatic deamination of cytidine.
Snider MJ; Reinhardt L; Wolfenden R; Cleland WW
Biochemistry; 2002 Jan; 41(1):415-21. PubMed ID: 11772041
[TBL] [Abstract][Full Text] [Related]
57. Adenosine deaminase, 5'-nucleotidase, guanase and cytidine deaminase activities in gastric tissues from patients with gastric cancer.
Durak I; Cetin R; Canbolat O; Cetin D; Yurtarslani Z; Unal A
Cancer Lett; 1994 Sep; 84(2):199-202. PubMed ID: 8076377
[TBL] [Abstract][Full Text] [Related]
58. Cytidine deamination and resistance to retroviral infection: towards a structural understanding of the APOBEC proteins.
Huthoff H; Malim MH
Virology; 2005 Apr; 334(2):147-53. PubMed ID: 15780864
[TBL] [Abstract][Full Text] [Related]
59. 9-[(Hydroxymethyl)phenyl]adenines: new aryladenine substrates of adenosine deaminase.
Brakta M; Murthy D; Ellis L; Phadtare S
Bioorg Med Chem Lett; 2002 Jun; 12(11):1489-92. PubMed ID: 12031326
[TBL] [Abstract][Full Text] [Related]
60. Heat shock proteins stimulate APOBEC-3-mediated cytidine deamination in the hepatitis B virus.
Chen Z; Eggerman TL; Bocharov AV; Baranova IN; Vishnyakova TG; Kurlander R; Patterson AP
J Biol Chem; 2017 Aug; 292(32):13459-13479. PubMed ID: 28637869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
